Stock listing
NYSE American:SER Serina Therapeutics, Inc. Stock
Home listing (NYSE American) of Serina Therapeutics, Inc.
Follow Serina Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · AMEX:SER
$1.85 USD -0.09 (-4.6%)
Close on Nov 2, 2026
- Day range
- $1.85 – $1.99 USDNov 2, 2026
- Volume
- 37,818 sharesNov 2, 2026
- Market cap
- $46.99M USDAt the close on Nov 2, 2026 · price × 25.40M shares outstanding
- 52-week range
- $1.22 – $4.99 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $156,892 USDMedian day 36,100 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE American:SER · Home | $1.85 USD | -0.09 (-4.6%) | 37,818 | $1.92 | $1.99 | $1.85 | $1.94 | Close on Nov 2, 2026 |
| Frankfurt:2BO | €1.64 EUR | +0.31 (+23.3%) | — | €1.64 | €1.64 | €1.61 | €1.33 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · AMEX:SER · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.85 | -0.09 | -4.6% | $1.92 | $1.99 | $1.85 | 37,818 | |
| $1.94 | +0.05 | +2.6% | $1.47 | $2.55 | $1.47 | 155,099 | |
| $1.89 | +0.25 | +15.2% | $1.51 | $1.99 | $1.485 | 60,508 | |
| $1.64 | -0.03 | -1.8% | $1.28 | $1.70 | $1.28 | 28,260 | |
| $1.67 | -0.04 | -2.3% | $1.38 | $1.75 | $1.38 | 172,032 | |
| $1.71 | +0.06 | +3.6% | $1.63 | $1.75 | $1.588 | 38,290 | |
| $1.65 | -0.11 | -6.3% | $1.73 | $1.76 | $1.65 | 8,000 | |
| $1.76 | -0.01 | -0.6% | $1.73 | $1.80 | $1.72 | 51,300 | |
| $1.77 | +0.11 | +6.6% | $1.67 | $1.78 | $1.63 | 39,800 | |
| $1.66 | +0.01 | +0.6% | $1.64 | $1.735 | $1.63 | 42,100 | |
| $1.65 | -0.07 | -4.1% | $1.75 | $1.81 | $1.65 | 22,000 | |
| $1.72 | -0.07 | -3.9% | $1.72 | $1.83 | $1.72 | 15,700 | |
| $1.79 | +0.08 | +4.7% | $1.71 | $1.94 | $1.71 | 27,400 | |
| $1.71 | -0.11 | -6.0% | $1.80 | $1.838 | $1.71 | 46,300 | |
| $1.82 | -0.12 | -6.2% | $1.92 | $1.974 | $1.78 | 26,300 | |
| $1.94 | -0.06 | -3.0% | $2.01 | $2.01 | $1.90 | 132,200 | |
| $2.00 | -0.01 | -0.5% | $1.99 | $2.05 | $1.99 | 22,300 | |
| $2.01 | 0.00 | 0.0% | $2.01 | $2.05 | $1.99 | 59,300 | |
| $2.01 | -0.03 | -1.5% | $2.04 | $2.08 | $2.01 | 12,900 | |
| $2.04 | 0.00 | 0.0% | $2.025 | $2.08 | $2.016 | 8,719 | |
| $2.04 | +0.08 | +4.1% | $2.10 | $2.10 | $1.965 | 25,270 | |
| $1.96 | +0.01 | +0.5% | $1.98 | $2.10 | $1.952 | 15,200 | |
| $1.95 | -0.05 | -2.5% | $1.96 | $2.06 | $1.95 | 46,800 | |
| $2.00 | -0.08 | -3.8% | $2.09 | $2.09 | $2.00 | 10,800 | |
| $2.08 | +0.07 | +3.5% | $1.97 | $2.13 | $1.97 | 15,775 | |
| $2.01 | -0.08 | -3.8% | $2.08 | $2.20 | $2.00 | 1,018,110 | |
| $2.09 | -0.05 | -2.3% | $2.13 | $2.197 | $2.09 | 28,400 | |
| $2.14 | -0.05 | -2.3% | $2.19 | $2.298 | $2.14 | 76,300 | |
| $2.19 | -0.12 | -5.2% | $2.30 | $2.315 | $2.17 | 7,900 | |
| $2.31 | 0.00 | 0.0% | $2.28 | $2.43 | $2.16 | 23,800 | |
| $2.31 | +0.06 | +2.7% | $2.15 | $2.371 | $2.00 | 31,000 | |
| $2.25 | +0.03 | +1.4% | $2.20 | $2.29 | $2.087 | 65,100 | |
| $2.22 | +0.06 | +2.8% | $2.26 | $2.31 | $2.18 | 30,000 | |
| $2.16 | -0.19 | -8.1% | $2.35 | $2.35 | $2.16 | 21,500 | |
| $2.35 | -0.10 | -4.1% | $2.46 | $2.47 | $2.25 | 31,700 | |
| $2.45 | +0.23 | +10.4% | $2.35 | $2.55 | $2.28 | 74,400 | |
| $2.22 | -0.28 | -11.2% | $2.41 | $2.54 | $2.20 | 69,300 | |
| $2.50 | -0.07 | -2.7% | $2.55 | $2.58 | $2.36 | 68,800 | |
| $2.57 | +0.07 | +2.8% | $2.75 | $2.78 | $2.35 | 404,100 | |
| $2.50 | -0.23 | -8.4% | $2.75 | $2.75 | $2.475 | 42,300 | |
| $2.73 | +0.04 | +1.5% | $2.70 | $2.74 | $2.512 | 14,900 | |
| $2.69 | +0.07 | +2.7% | $2.68 | $2.69 | $2.575 | 18,000 | |
| $2.62 | +0.12 | +4.8% | $2.50 | $2.67 | $2.42 | 70,946 | |
| $2.50 | +0.08 | +3.3% | $2.40 | $2.54 | $2.38 | 32,637 | |
| $2.42 | -0.04 | -1.6% | $2.40 | $2.50 | $2.38 | 23,116 | |
| $2.46 | -0.06 | -2.4% | $2.52 | $2.53 | $2.41 | 33,800 | |
| $2.52 | -0.11 | -4.2% | $2.61 | $2.643 | $2.52 | 29,500 | |
| $2.63 | -0.07 | -2.6% | $2.67 | $2.70 | $2.56 | 15,500 | |
| $2.70 | +0.07 | +2.7% | $2.73 | $2.80 | $2.55 | 27,400 | |
| $2.63 | -0.24 | -8.4% | $2.77 | $2.855 | $2.63 | 36,100 | |
| $2.87 | +0.22 | +8.3% | $2.67 | $2.87 | $2.618 | 46,100 | |
| $2.65 | -0.07 | -2.6% | $2.64 | $2.695 | $2.56 | 24,800 | |
| $2.72 | +0.10 | +3.8% | $2.70 | $2.84 | $2.56 | 158,400 | |
| $2.62 | -0.23 | -8.1% | $2.71 | $2.86 | $2.61 | 52,100 | |
| $2.85 | +0.05 | +1.8% | $2.72 | $2.916 | $2.64 | 133,500 | |
| $2.80 | -0.05 | -1.8% | $2.64 | $2.88 | $2.64 | 75,900 | |
| $2.85 | +0.03 | +1.1% | $2.81 | $2.85 | $2.70 | 54,400 | |
| $2.82 | +0.04 | +1.4% | $2.80 | $2.82 | $2.675 | 108,600 | |
| $2.78 | +0.11 | +4.1% | $2.69 | $2.86 | $2.68 | 118,100 | |
| $2.67 | +0.27 | +11.3% | $2.37 | $2.73 | $2.31 | 139,100 | |
| $2.40 | +0.05 | +2.1% | $2.36 | $2.40 | $2.33 | 26,600 | |
| $2.35 | +0.12 | +5.4% | $2.14 | $2.39 | $2.14 | 70,900 | |
| $2.23 | +0.09 | +4.2% | $2.04 | $2.23 | $2.04 | 35,000 | |
| $2.14 | +0.08 | +3.9% | $2.11 | $2.237 | $2.10 | 45,000 | |
| $2.06 | +0.06 | +3.0% | $2.00 | $2.11 | $2.00 | 17,600 |
- Ticker
- NYSE American:SER
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NYSE American
- Currency
- USD
What changed lately
Latest news release · Sep 9, 2026
Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 20 slides
Latest news
Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2
Sep 9, 2026
Closed $2.57 (+2.8%) on Sep 9, 2026
Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit
Apr 7, 2026
Closed $2.08 (-3.3%) on Apr 7, 2026
Serina Therapeutics Announces NYSE American Acceptance of Continued Listing Compliance Plan
Apr 2, 2026
Closed $2.15 (+1.4%) on Apr 6, 2026
Serina Therapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights
Mar 25, 2026
Closed $2.61 (-13.9%) on Mar 26, 2026
Serina Therapeutics to Present at the 38th Annual Roth Conference
Mar 24, 2026
Closed $2.43 (-22.9%) on Mar 24, 2026
Serina Therapeutics Secures up to $30 Million in Private Placement to Advance Registrational Trial of SER-252 for Advanced Parkinson’s Disease
Mar 18, 2026
Closed $2.48 (+93.8%) on Mar 19, 2026
Serina Therapeutics Announces Dosing of First Patient in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
Feb 24, 2026
Closed $1.77 (+6.0%) on Feb 25, 2026
Serina Therapeutics Announces FDA Clearance of IND Application for SER-252 for the Treatment of Advanced Parkinson’s disease
Jan 28, 2026
Closed $3.54 (+30.1%) on Jan 29, 2026
Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders' Equity
Jan 15, 2026
Closed $3.10 (+15.2%) on Jan 16, 2026
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry
Dec 11, 2025
Closed $3.12 (-0.6%) on Dec 12, 2025
Decks
Investor Presentation (September 2026)
Investor deck · 20 slides · September 2026
Investor Presentation (July 2025)
Investor deck · 22 slides · Jul 29, 2025
4th LNP Formulation & Process Development Summit 2025
Conference · 36 slides · Apr 15, 2025
Investor Presentation (April 2025)
Investor deck · 26 slides · Apr 7, 2025
Serina Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 13 in the last 12 months · 31 in all · newest Sep 9, 2026 · oldest 2025
- Decks
- 11 decks · latest September 2026
Where Serina Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE American:SER · Home listing · This page | NYSE American | United States | USD |
| Tradegate:2BO | Tradegate | Germany | EUR |
| BOATS:SER | BOATS | United States | USD |
| gettex:2BO | gettex | Germany | EUR |
| Lang & Schwarz:A407RQ | Lang & Schwarz | Germany | EUR |
| Frankfurt:2BO | Frankfurt | Germany | EUR |
Log in to ask 6ix AI your own questions about Serina Therapeutics, Inc.